StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a research report sent to investors on Sunday morning. The brokerage issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Stock Performance
Shares of NYSE CO opened at $1.25 on Friday. The stock has a fifty day moving average price of $1.44 and a 200 day moving average price of $1.36. Global Cord Blood has a 12-month low of $2.03 and a 12-month high of $5.50. The company has a market cap of $151.94 million, a P/E ratio of 1.95 and a beta of 0.16.
Global Cord Blood Company Profile
Featured Articles
- Five stocks we like better than Global Cord Blood
- Insider Buying Explained: What Investors Need to Know
- AMD is Down 35%. Now is the Time to Buy the Dip
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Amazon Stands Tall: New Highs Are in Sight
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.